12 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

EXCELSIUS GPS

FDA 510(k)
FDA Class 2 ·Neurology

Novo Surgical

FDA UDI
NOVO SURGICAL, INC.·G586G1716510·tissue forceps, standard pattern, serrated hand...

RHEAD

FDA UDI
Stryker GmbH·00886385023861·Stem Trial; Extended Collar; Size 3

EGS SEROSAFUSE IMPLANTABLE FASTENERS, ASSOCIATED DELIVERY DEVICES AND ACCESSORIES

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

ANGIOGUARD XP EMBOLI CAPTURE GUIDEWIRE, ANGIOGUARD RX EMBOLI CAPTURE GUIDEWIRE

FDA 510(k)
FDA Class 2 ·Cardiovascular

TROCHANTERIC NAIL KIT, TI GAMMA3 10X170MM X 125

FDA Adverse Event
Injury ·STRYKER OSTEOSYNTHESIS KIEL·Product code HSB·September 14, 2012

EQUINOXE REVERSE SHOULDER COMPONENTS

FDA Adverse Event
Injury ·EXACTECH, INC.·Product code KWT·July 13, 2023

TRI-LOCK BPS SZ 8 HI OFFSET

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS INC US·Product code KWA·October 14, 2014

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

FDA Adverse Event
Malfunction ·AV-TEMECULA-CT·Product code NIQ·July 21, 2011

ORACLE CAGE 55*22 H15 8° PEEK

FDA Adverse Event
Malfunction ·SYNTHES MONUMENT·Product code MAX·June 15, 2013

CADD-Solis VIP ambulatory infusion pump, Model Numbers: a. 21-2120-0105-02L b. 21-2120-0105-03L c. 21-2120-0105-06L d. 21-2120-0105-07L e. 21-2120-0105-08L f. 21-2120-0105-12L g. 21-2120-0105-13L h. 21-2120-0105-14L i. 21-2120-0105-15L j. 21-2120-0105-17L k. 21-2120-0105-50L l. 21-2127-0105-02L m. 21-2127-0105-06L n. 21-2127-0105-50L

FDA Enforcement
Class I ·Terminated·Smiths Medical ASD Inc.·October 27, 2021

Merlin PCS Programmer software model 3330, used with Confirm Rx Insertable Cardiac Monitor (ICM), Model DM3500, Sterile. The firm name on the label of the ICM is St. Jude Medical Cardiac Rhythm Management Division, Sylmar, CA. - Product Usage: The Confirm Rx insertable cardiac monitor is designed to detect arrhythmias and wirelessly transmit data to the Merlin.net Patient Care Network. The Confirm Rx ICM is indicated for the monitoring and diagnostic evaluation of patients who experience unexplained symptoms such as: dizziness, palpitations, chest pain, syncope, and shortness of breath, as well as patients who are at risk for cardiac arrhythmias. It is also indicated for patients who have been previously diagnosed with atrial fibrillation or who are susceptible to developing atrial fibrillation.

FDA Enforcement
Class II ·Terminated·St Jude Medical, Cardiac Rhythm Management Division·January 22, 2020